Pages that link to "Template:Immunosuppressants"
From Self-sufficiency
The following pages link to Template:Immunosuppressants:
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Azathioprine (transclusion) (← links)
- International Classification of Diseases for Oncology (← links)
- List of ICD-9 codes 140-239: neoplasms (← links)
- ICD-10 Chapter II: Neoplasms (← links)
- List of ICD-9 codes 240-279: endocrine, nutritional and metabolic diseases, and immunity disorders (← links)
- ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism (← links)
- ATC code L (transclusion) (← links)
- ATC code L03 (← links)
- ATC code L04 (transclusion) (← links)
- Immunostimulant (← links)
- Drug eruption (← links)
- Belatacept (transclusion) (← links)
- Gavilimomab (transclusion) (← links)
- Faralimomab (transclusion) (← links)
- Aselizumab (transclusion) (← links)
- Atorolimumab (transclusion) (← links)
- Belimumab (transclusion) (← links)
- Bertilimumab (transclusion) (← links)
- Cedelizumab (transclusion) (← links)
- Ipilimumab (transclusion) (← links)
- Lerdelimumab (transclusion) (← links)
- Metelimumab (transclusion) (← links)
- Zanolimumab (transclusion) (← links)
- Zolimomab aritox (transclusion) (← links)
- Elsilimomab (transclusion) (← links)
- Inolimomab (transclusion) (← links)
- Odulimomab (transclusion) (← links)
- Vepalimomab (transclusion) (← links)
- Galiximab (transclusion) (← links)
- Gomiliximab (transclusion) (← links)
- Maslimomab (transclusion) (← links)
- Keliximab (transclusion) (← links)
- Lumiliximab (transclusion) (← links)
- Teneliximab (transclusion) (← links)
- Vapaliximab (transclusion) (← links)
- Tremelimumab (transclusion) (← links)
- Erlizumab (transclusion) (← links)
- Fontolizumab (transclusion) (← links)
- Pascolizumab (transclusion) (← links)
- Pexelizumab (transclusion) (← links)
- Reslizumab (transclusion) (← links)
- Rovelizumab (transclusion) (← links)
- Ruplizumab (transclusion) (← links)
- Siplizumab (transclusion) (← links)
- Talizumab (transclusion) (← links)
- Toralizumab (transclusion) (← links)
- Visilizumab (transclusion) (← links)
- Nerelimomab (transclusion) (← links)
- Morolimumab (transclusion) (← links)
- Teplizumab (transclusion) (← links)